Search Login Register
Eosinophilic Esophagitis
Summary
Description:
Chronic ESOPHAGITIS characterized by esophageal mucosal EOSINOPHILIA. It is diagnosed when an increase in EOSINOPHILS are present over the entire esophagus. The reflux symptoms fail to respond to PROTON PUMP INHIBITORS treatment, unlike in GASTROESOPHAGEAL REFLUX DISEASE. The symptoms are associated with IgE-mediated hypersensitivity to food or inhalant allergens.
Also Known As:
Chronic Esophagitis, Eosinophilic; Chronic Esophagitides, Eosinophilic; Eosinophilic Chronic Esophagitides; Eosinophilic Chronic Esophagitis; Eosinophilic Esophagitides Show All >>
Networked: 362
relevant articles (20 outcomes,
27 trials/studies)
for this Disease
Key Drugs and Agents for Eosinophilic Esophagitis
Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
-
Budesonide (Pulmicort)
:
4 outcomes 1 study in 15 results
:
FDA 10
Generic
-
Adrenal Cortex Hormones (Corticosteroids)
:
4 outcomes in 23 results
: IBA
-
fluticasone (Cutivate)
:
2 outcomes 2 studies in 17 results
:
FDA 23
Generic
-
montelukast (Singulair)
:
2 outcomes 1 study in 4 results
:
FDA 10
-
Proton Pumps (Proton Pump)
:
1 outcome 4 studies in 24 results
: IBA
-
Phenobarbital (Luminal)
:
1 outcome 1 study in 4 results
:
FDA 1
-
Interleukins
:
1 outcome 1 study in 4 results
: IBA
-
mepolizumab
:
1 outcome 1 study in 4 results
: IBA
-
Allergens
:
1 outcome in 20 results
: IBA
-
Steroids
:
1 outcome in 16 results
: IBA
Show All >>
Diseases Related to Eosinophilic Esophagitis
-
Eosinophilia
-
Asthma (Bronchial Asthma)
-
Atopic Dermatitis (Atopic Eczema)
-
Rhinitis
-
Hypereosinophilic Syndrome (Loeffler Endocarditis)
Show All >>
Key Therapies for Eosinophilic Esophagitis
Efficacy Chart >>
-
Immunotherapy
:
6 results
-
Fundoplication
:
5 results
-
Drug Therapy (Chemotherapy)
:
5 results
-
Diet Therapy (Therapy, Diet)
:
3 results
-
Transplants (Transplant)
:
2 results
Show All >>
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.